These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10434227)

  • 1. Raloxifene, a new selective estrogen receptor modulator.
    Goldfrank D; Haytoglu T; Frishman WH; Mohammad Z
    J Clin Pharmacol; 1999 Aug; 39(8):767-74. PubMed ID: 10434227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of raloxifene hydrochloride in women.
    Khovidhunkit W; Shoback DM
    Ann Intern Med; 1999 Mar; 130(5):431-9. PubMed ID: 10068418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encouraging news from the SERM frontier. Selective estrogen receptor modulator.
    Franks AL; Steinberg KK
    JAMA; 1999 Jun; 281(23):2243-4. PubMed ID: 10376579
    [No Abstract]   [Full Text] [Related]  

  • 4. Raloxifene: a selective estrogen receptor modulator.
    Scott JA; Da Camara CC; Early JE
    Am Fam Physician; 1999 Sep; 60(4):1131-9. PubMed ID: 10507743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women.
    Nickelsen T; Lufkin EG; Riggs BL; Cox DA; Crook TH
    Psychoneuroendocrinology; 1999 Jan; 24(1):115-28. PubMed ID: 10098223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
    Walsh BW; Kuller LH; Wild RA; Paul S; Farmer M; Lawrence JB; Shah AS; Anderson PW
    JAMA; 1998 May; 279(18):1445-51. PubMed ID: 9600478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective estrogen receptor modulators: an alternative to hormone replacement therapy.
    Bryant HU; Dere WH
    Proc Soc Exp Biol Med; 1998 Jan; 217(1):45-52. PubMed ID: 9421206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH; Komm BS
    Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An estrogen receptor basis for raloxifene action in bone.
    Bryant HU; Glasebrook AL; Yang NN; Sato M
    J Steroid Biochem Mol Biol; 1999; 69(1-6):37-44. PubMed ID: 10418979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.
    Mijatovic V; van der Mooren MJ; Stehouwer CD; Netelenbos JC; Kenemans P
    Gynecol Endocrinol; 1999 Apr; 13(2):130-44. PubMed ID: 10399059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective estrogen receptor modulators: a look ahead.
    Mitlak BH; Cohen FJ
    Drugs; 1999 May; 57(5):653-63. PubMed ID: 10353293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective estrogen receptor modulators and postmenopausal women's health.
    Hol T; Cox MB; Bryant HU; Draper MW
    J Womens Health; 1997 Oct; 6(5):523-31. PubMed ID: 9356975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
    Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
    J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulator.
    Palkowitz AD; Glasebrook AL; Thrasher KJ; Hauser KL; Short LL; Phillips DL; Muehl BS; Sato M; Shetler PK; Cullinan GJ; Pell TR; Bryant HU
    J Med Chem; 1997 May; 40(10):1407-16. PubMed ID: 9154963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing.
    Buelke-Sam J; Bryant HU; Francis PC
    Reprod Toxicol; 1998; 12(3):217-21. PubMed ID: 9628546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogen receptor and selective estrogen receptor modulators (SERMs)].
    Shioi A; Nishizawa Y
    Nihon Rinsho; 1999 May; 57(5):1199-207. PubMed ID: 10361456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiestrogenic action of raloxifene and tamoxifen: today and tomorrow.
    Jordan VC
    J Natl Cancer Inst; 1998 Jul; 90(13):967-71. PubMed ID: 9665143
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene.
    Barrett-Connor E; Wenger NK; Grady D; Mosca L; Collins P; Kornitzer M; Cox DA; Moscarelli E; Anderson PW
    J Womens Health; 1998 Sep; 7(7):839-47. PubMed ID: 9785310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective estrogen receptor modulators: a new category of therapeutic agents for extending the health of postmenopausal women.
    Goldstein SR
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1479-84. PubMed ID: 9855584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Raloxifene: a selective modulator of estrogen receptors].
    van den Brûle FA; Kalbus MF; Gaspard UJ
    J Gynecol Obstet Biol Reprod (Paris); 1999 Dec; 28(8):788-99. PubMed ID: 10635481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.